NDC 10144-594

Zanaflex

Tizanidine Hydrochloride

Zanaflex is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Acorda Therapeutics, Inc.. The primary component is Tizanidine Hydrochloride.

Product ID10144-594_7897aa33-13b7-f553-e053-2a91aa0a2c3f
NDC10144-594
Product TypeHuman Prescription Drug
Proprietary NameZanaflex
Generic NameTizanidine Hydrochloride
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1997-01-01
Marketing End Date2020-09-30
Marketing CategoryNDA / NDA
Application NumberNDA020397
Labeler NameAcorda Therapeutics, Inc.
Substance NameTIZANIDINE HYDROCHLORIDE
Active Ingredient Strength4 mg/1
Pharm ClassesAdrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
NDC Exclude FlagN

Packaging

NDC 10144-594-15

150 TABLET in 1 BOTTLE (10144-594-15)
Marketing Start Date2017-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10144-594-15 [10144059415]

Zanaflex TABLET
Marketing CategoryNDA
Application NumberNDA020397
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-01-01
Marketing End Date2020-09-30

Drug Details

Active Ingredients

IngredientStrength
TIZANIDINE HYDROCHLORIDE4 mg/1

OpenFDA Data

SPL SET ID:413ee468-c7e8-4283-8e2b-b573dcc1f607
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 583211
  • 583165
  • 580267
  • 313413
  • 485485
  • 485484
  • 153735
  • 485486
    • UPC Code
  • 0310144594151
  • 0310144606151
  • 0310144602153

    • Pharmacological Class

    • Adrenergic alpha2-Agonists [MoA]
    • Central alpha-2 Adrenergic Agonist [EPC]
    • Adrenergic alpha2-Agonists [MoA]
    • Central alpha-2 Adrenergic Agonist [EPC]

    NDC Crossover Matching brand name "Zanaflex" or generic name "Tizanidine Hydrochloride"

    NDCBrand NameGeneric Name
    10144-594Zanaflextizanidine hydrochloride
    10144-602Zanaflextizanidine hydrochloride
    10144-604Zanaflextizanidine hydrochloride
    10144-606Zanaflextizanidine hydrochloride
    21695-373Zanaflextizanidine hydrochloride
    70515-594ZanaflexZanaflex
    70515-604ZanaflexZanaflex
    70515-602ZanaflexZanaflex
    70515-606ZanaflexZanaflex
    55289-612ZanaflexZanaflex
    80425-0022ZanaflexZanaflex
    80425-0024ZanaflexZanaflex
    80425-0090ZanaflexZanaflex
    80425-0023ZanaflexZanaflex
    0185-0034tizanidine hydrochloridetizanidine hydrochloride
    0185-4400tizanidine hydrochloridetizanidine hydrochloride
    0591-2788tizanidine hydrochloridetizanidine hydrochloride
    0591-2789tizanidine hydrochloridetizanidine hydrochloride
    0591-2790tizanidine hydrochloridetizanidine hydrochloride
    21695-126TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE
    21695-127TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE
    35356-662TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE
    42291-810Tizanidine HydrochlorideTizanidine Hydrochloride
    42291-811Tizanidine HydrochlorideTizanidine Hydrochloride
    42291-812Tizanidine HydrochlorideTizanidine Hydrochloride
    45865-954Tizanidine HydrochlorideTizanidine Hydrochloride
    46708-491Tizanidine HydrochlorideTizanidine Hydrochloride
    46708-492Tizanidine HydrochlorideTizanidine Hydrochloride
    46708-493Tizanidine HydrochlorideTizanidine Hydrochloride
    49884-611tizanidine hydrochloridetizanidine hydrochloride
    49884-719tizanidine hydrochloridetizanidine hydrochloride
    49884-765tizanidine hydrochloridetizanidine hydrochloride
    49999-347Tizanidine HydrochlorideTizanidine Hydrochloride

    Trademark Results [Zanaflex]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZANAFLEX
    ZANAFLEX
    75186534 2383531 Live/Registered
    COVIS PHARMA B.V.
    1996-10-15
    ZANAFLEX
    ZANAFLEX
    74400930 1906277 Dead/Cancelled
    ELAN PHARMACEUTICALS, INC.
    1993-06-09
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.